INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

76,400 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
RP
Robertson Stephen P.Chief Legal Officer
AUPHAurinia Pharmaceuticals Inc.
Grant or award
A—
115.5K sh
May 18, 2026
Page 926 of 1910
← PrevNext →
May 20, 2026
traded May 18, 2026
+2d
SEC Form 4

Evidence

17
JW
Jiang WenbinDirector, PRESIDENT AND CEO
CTKBCytek Biosciences, Inc.
Option exercise
M—
7,854 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
MJ
Ma JiongDirector
SESSES AI Corp
Grant or award
A—
141.6K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
4,908 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
TH
Telman Deborah HDirector
ATRCAtriCure, Inc.
Grant or award
A—
6,144 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$2.24M
10.3K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.13M
5,200 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
3,962 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

17
PK
Pilkington KyleCHIEF LEGAL OFFICER
SESSES AI Corp
Grant or award
A—
354.0K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
PR
Patton Charles R.Director
CTRICenturi Holdings, Inc.
Option exercise
M—
7,338 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
1,024 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

17
MC
Marcus CatherineDirector
TILEINTERFACE INC
Grant or award
A—
4,461 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

17
HQ
Hu QichaoDirector, CEO & CHAIRMAN, 10% Owner
SESSES AI Corp
Grant or award
A—
1.50M sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

16
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$257K
34.3K sh
May 20, 2026May 20, 2026
traded May 20, 2026
+0dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$1,747
380 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
PP
PWP VoteCo Professionals LPDirector
PWPPerella Weinberg Partners
Other acquisition or disposition
J$38K
1.91M sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

16
IC
Iriarte Esteban CDirector
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Grant or award
A$95K
1,873 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

16
AS
Arora SumeetChief Product Officer
TDCTERADATA CORP /DE/
Open-market sale · 10b5-1 plan
SELL$495K
15.0K sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

15
KA
Kharsansky AlanChief Technology Officer
SATLSatellogic Inc.
Option exercise
M—
87.1K sh
May 14, 2026May 20, 2026
traded May 14, 2026
+6dSEC Form 4

Evidence

15
EJ
Ederer JohnChief Financial Officer
TDCTERADATA CORP /DE/
Tax withholding
F$438K
13.4K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$541K
2,400 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
2,375 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
1,158 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$520K
2,356 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$391K
1,782 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$710K
3,247 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$36K
2,477 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$538K
2,320 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MA
Maheshwari AnshulChief Financial Officer
SIBNSI-BONE, Inc.
Open-market sale
SELL$32K
2,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$662K
2,841 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
PJ
Parikh Shamik JChief Medical Officer
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
1,848 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$280K
1,189 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
SA
Sander Dale A.CFO and Chief Corp. Dev. Off
HUMAHumacyte, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
45.9K sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
1,996 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
BP
Busque PhilippeSVP, GLOBAL SALES AND SERVICES
CTKBCytek Biosciences, Inc.
Option exercise
M—
5,551 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
KR
Kappus Anthony RayGM & Chief Operating Officer
UPWKUPWORK, INC
Option exercise
M—
5,114 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
YM
Yan MingDirector, CHIEF TECHNOLOGY OFFICER
CTKBCytek Biosciences, Inc.
Option exercise
M—
3,683 sh
May 18, 2026May 20, 2026
traded May 18, 2026
+2dSEC Form 4

Evidence

13
OT
O'Brien Robert TDirector
TILEINTERFACE INC
Grant or award
A—
4,461 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,501
761 sh
May 19, 2026May 20, 2026
traded May 19, 2026
+1dSEC Form 4

Evidence